Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of platelet aggregation with ticagrelor, clopidogrel, and prasugrel and correlation with CYP2C19 polymorphisms in Thai patients undergoing coronary angiography
TCTR20170303002Active, not recruiting
- Sponsor
- Faculty of Medicine, Chulalongkorn University
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of ticagrelor, clopidogrel and prasugrel in coronary arteriosclerosis (3 arms), sponsored by Faculty of Medicine, Chulalongkorn University. Primary endpoints: Platelet aggregation after loading dose and Correlation of platelet aggregation response with CYP2C19 polymorphisms. Started Feb 2016; status: active, not recruiting.
02
Drugs
ticagrelorclopidogrelprasugrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on TCTR20170303002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170303002.